This browser is no longer supported

Please switch to a supported browser to continue using this website.
Consider using the latest version of Google Chrome or Microsoft's Edge to view this website.

Investors

CSL's 2021 R&D Investor Briefing - Announcement

CSL's 2021 R&D Investor Briefing webcast was broadcast on Tuesday, 19th October 2021 (AEDT).

Details including Presentation Slides, Speaker Biographies and Webcast Recording are now available.
Time
9:00am (AEDT)

COVID-19: A Message from Our CEO

"As the COVID-19 pandemic evolves, CSL remains committed to safeguarding our patients, our donors and our people. In keeping with our values-based culture, CSL has taken precautions to ensure our employees and our facilities remain safe so we can continue to deliver on our promise to patients and public health." - Paul Perreault, CEO & Managing Director, CSL Limited

SHARE PRICE

CSL Mkt Cap:
The Market is currently
Price Delay ~20min
Read More

FINANCIAL RESULTS

Annual General Meeting (AGM) Information

CSL's 2021 AGM was held on Tuesday, 12th October 2021 (AEDT).

Learn More

View our interactive online annual report 2021

Introduction to CSL

See how we are driven by our promise.

Learn More

Board and Management

View our Board and Management here.

Learn More

Corporate Governance

View our corporate governance here.

Learn More